ACD PHARMACEUTICALS AS: årsregnskap 2019 vs 2018
A steady year on the published lines
approved 2020-06-30; registry 2020-09-21; journal 2020 837544
Summary
What changed
Comparing Årsregnskap 2019 with 2018 for ACD PHARMACEUTICALS AS. Revenue 19.46m NOK → 20.03m NOK (+2.9%). Equity 2.34m NOK → 2.77m NOK.
On the constructive side: revenue rose; equity strengthened. Pressures included: cash fell.
Also worth watching: cogs moved. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
Revenue
19.46m NOK
20.03m NOK
+2.9%
Operating result
n/m
+10.20m NOK
—
Net result
n/m
+10.44m NOK
—
Equity
2.34m NOK
2.77m NOK
+18.7%
Cash
162.9k NOK
141.0k NOK
-13.4%
Total assets
18.33m NOK
16.20m NOK
-11.6%
What improved
-
↑
Revenue rose
Operating income / revenue moved from 19.46m NOK to 20.03m NOK (+2.9% YoY). Calculated
-
↑
Equity strengthened
Book equity 2.34m NOK → 2.77m NOK (equity ratio 12.7% → 17.1%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 162.9k NOK → 141.0k NOK (-13.4% YoY). Calculated
Things to notice
-
·
COGS moved
COGS / varekostnad 335.4k NOK → 580.7k NOK (+73.1% YoY). Calculated